I-MAB BIOPHARMA

Live / Registered — Registered (as of 25 Jan 2022)

What this means for you

Registered since 25 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
88517411
Registration number
6629613
Mark type
Design + words
Filed
16 Jul 2019
Published for opposition
07 Sept 2021
Registered
25 Jan 2022
Attorney of record
Jacqueline Lesser

Goods and services

  • Class 005 — Pharmaceuticals: Monoclonal antibodies for use in disease testing; biological preparations for the treatment of cancer, tumor suppressing agents, anti-cancer preparations, and pharmaceutical preparations for the treatment of immune system related diseases and disorders, all comprising monoclonal antibodies
  • Class 042 — Scientific and technological services: Biomedical research services; conducting early evaluations in the field of new pharmaceuticals; quality control of goods and services; product quality testing; pharmaceutical product evaluation; biological research; conducting clinical trials for others that feature or contain monoclonal antibodies; research and development services in the field of antibodies

Owner

Prosecution history

  • 01 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 01 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 01 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 16 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 16 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 16 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 16 Apr 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 16 Apr 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 25 Dec 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 17 May 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 25 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
  • 24 Dec 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 23 Dec 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 23 Dec 2021 — EXAMINER'S AMENDMENT ENTERED
  • 23 Dec 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

View this trademark record on Marksy